Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity-Reference-Cited by-同舟云学术

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

Published:2017-04-06 Issue:7 Volume:19 Page:918-929
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Hiraoka Kei,Inagaki Akihito,Kato Yuki,Huang Tiffany T.,Mitchell Leah A.,Kamijima Shuichi,Takahashi Masamichi,Matsumoto Hiroshi,Hacke Katrin,Kruse Carol A.,Ostertag Derek,Robbins Joan M.,Gruber Harry E.,Jolly Douglas J.,Kasahara Noriyuki

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/7/918/17721531/nox038.pdf

Reference26 articles.

1. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors;Curr Gene Ther,2005

2. Retroviral replicating vectors in cancer;Methods Enzymol,2012

3. Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivity;J Virol,2014

4. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection;Mol Cell Biol,1990

5. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines;Oncogene,2014

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma;Neuro-Oncology;2024-08-08

2. Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model;Cancer Gene Therapy;2024-07-23

3. IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma;2024-04-03

4. Engineering the Active Site Lid Dynamics to Improve the Catalytic Efficiency of Yeast Cytosine Deaminase;International Journal of Molecular Sciences;2023-04-01

5. Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer;Cancers;2022-11-25